KAT6B and carcinoma: TP53 was one of the two genes with a significant consistent trend in mutation prevalence towards malignancy, while four other genes (HNF1A, KAT6B, FBXW7, and NFKB1) exhibited the opposite trend, with mutation frequencies decreasing towards carcinoma.